Mirtazapine Is Not a Controlled Substance: Here’s Why

Mirtazapine is not a controlled substance. It is not listed on any of the five DEA schedules of controlled substances under federal law (21 CFR Part 1308), meaning the government does not consider it to have significant potential for abuse or dependence. You do still need a prescription to get it, but it carries none of the extra restrictions that apply to controlled medications like opioids, benzodiazepines, or stimulants.

What Mirtazapine Is Prescribed For

Mirtazapine is an antidepressant approved by the FDA for the treatment of major depressive disorder in adults. It is sold under the brand name Remeron. The typical starting dose is 15 mg taken once daily, usually in the evening, and doctors can increase it up to 45 mg per day if needed.

It works differently from more widely known antidepressants like SSRIs. Rather than blocking the reabsorption of serotonin, mirtazapine increases the activity of both serotonin and norepinephrine by blocking certain receptors that normally act as brakes on those systems. It also strongly blocks histamine receptors, which is why drowsiness is one of its most noticeable effects. That sedating quality is sometimes the reason doctors choose it over other antidepressants, particularly for patients who also struggle with insomnia or poor appetite, since it tends to increase both sleep and hunger.

Why It’s Not Considered a Controlled Substance

The DEA schedules drugs based on their potential for abuse, whether they cause physical or psychological dependence, and whether they have accepted medical uses. Mirtazapine doesn’t produce euphoria or the kind of reward response that drives people to misuse a drug recreationally. Its most prominent side effects, drowsiness and weight gain, are the opposite of what people typically seek from substances with abuse potential.

Researchers have noted mirtazapine’s safety profile as a specific advantage over other medications being studied for addiction treatment. A 2024 clinical trial published in JAMA Psychiatry highlighted that mirtazapine “can be easily and safely prescribed in an outpatient setting with limited clinical oversight,” in contrast to other drugs under investigation that require close supervision due to risks of overdose, toxicity, and abuse liability.

Prescription Required, but Fewer Restrictions

Being non-controlled doesn’t mean you can buy mirtazapine over the counter. In the United States, the United Kingdom, Canada, and Australia, you need a doctor’s prescription. The difference is in what happens at the pharmacy and the doctor’s office. Controlled substances come with tighter rules: limits on refills, requirements for new prescriptions each month, restrictions on phone-in orders, and in some cases mandatory monitoring through prescription drug databases. None of those apply to mirtazapine. Your doctor can call in refills, and pharmacies handle it like any other standard prescription medication.

Discontinuation Effects Are Not the Same as Addiction

If you’ve been taking mirtazapine for a while and stop abruptly, you may experience uncomfortable symptoms like dizziness, nausea, anxiety, or irritability. This is called discontinuation syndrome, and it happens with many antidepressants, not just mirtazapine. It’s a sign that your body has adjusted to the medication’s presence, not a sign of addiction.

The distinction matters. Addiction involves compulsive drug-seeking behavior, cravings, and continued use despite harm. Discontinuation syndrome is a temporary physical adjustment that can be managed by gradually reducing the dose over time rather than stopping all at once. Interestingly, a large 2024 systematic review in The Lancet Psychiatry noted that no formal studies have measured the exact incidence of discontinuation symptoms specifically for mirtazapine, which reflects how relatively low-priority this concern has been in the research community compared to other antidepressants.

If you’re planning to stop taking mirtazapine, tapering slowly under your prescriber’s guidance is the standard approach to minimizing any withdrawal-like symptoms.

How It Compares to Controlled Medications for Sleep and Anxiety

People sometimes search whether mirtazapine is controlled because it’s been prescribed for sleep or anxiety, conditions more commonly treated with controlled substances like benzodiazepines or sleep aids. Mirtazapine’s strong sedating effect at lower doses makes it a practical option when doctors want to avoid prescribing something with higher abuse potential. At 15 mg, the sedation tends to be more pronounced than at higher doses, which is why it’s often taken at bedtime.

This is one reason mirtazapine shows up in treatment plans for people with a history of substance use disorders. Doctors can address depression, insomnia, and poor appetite with a single non-controlled medication, reducing the need to introduce drugs that carry stricter monitoring requirements or higher misuse risk.